Patent · US Active

Stabilized insulin-like growth factor polypeptides

US10167329B2 · kind B2 · utility

0Cited by

4References

14Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Mara Fornaro · Basel, CH
Thomas Huber · Basel, CH
Mauro Zurini · Basel, CH

Key dates

Filing date	Dec 16, 2013
Grant date	Jan 1, 2019
Priority date	—
Expiry date	Dec 16, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention is in the field of IGF-1 modifications. In particular, it relates to modified IGF-polypeptides and modified IGF-1 precursor polypeptides wherein the cleavage of E-peptide is prevented. The invention also relates to the use of such polypeptides for treating muscle diseases and disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.